학술논문
GS13 - Ledipasvir/Sofosbuvir for 12 or 24 Weeks Is Safe and Effective in Kidney Transplant Recipients with Chronic Genotype 1 or 4 Hcv Infection
Document Type
Abstract
Author
Source
In Journal of Hepatology 2016 64(2) Supplement:S183-S183
Subject
Language
ISSN
0168-8278